Overview
SynapCell develops integrated electrophysiology platforms and predictive biomarkers for epilepsy and mesial temporal lobe epilepsy (MTLE) research and drug development. The company's technology combines pharmacoEEG, auditory event-related potentials (aERP), and neural network analysis to enable early detection and patient stratification in neurological disorders.
More in Neurotechnology
Latest industry news
China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race
2026-07-16 · Industry
NIH Confirms Brain-Computer Device Restores Speech in Human Patient
2026-07-15 · Research
Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans
2026-07-14 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-13 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →